D-0996-2019 Class III Terminated
FDA drug recall D-0996-2019 was initiated by Lannett Company Inc. on Feb 21, 2019 and is designated Class III. Reason for recall: Failed Dissolution Specifications The recall status is terminated (terminated Nov 6, 2020). Affected quantity: 14,448 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Mar 20, 2019
- Initiation Date
- Feb 21, 2019
- Termination Date
- Nov 6, 2020
- Product Quantity
- 14,448 bottles
Product description
Oxybutynin Chloride, Extended-Release Tablets USP, 10 mg, 100 Tablet, Rx Only, Distributed by: Lannett Company, Inc, Philadelphia, PA 19154 NDC: 62175-271-37
Reason for recall
Failed Dissolution Specifications
Distribution pattern
Nationwide, including Puerto Rico.
Code information
Lots: 18226783A, exp 07/2021 and 18232540A, exp 08/2021
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0996-2019
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026